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Abstract 
Problem:  The Patient Centered Medical Home (PCMH) is a model of care that improves 
the quality and experience of care and decreases cost. Use of a validated depression 
screening tool for adult patients is a PCMH certification requirement. The purpose of this 
quality initiative was to obtain baseline data when a depression screening tool was 
utilized among adult patients in an internal medicine clinic within a Midwestern public 
health department.  
Methods:  This was a quality improvement project utilizing a descriptive and 
observational design. A retrospective medical record review was used to assess the rate of 
depression screening utilizing the PHQ-2 and PHQ-9, while also assessing use of 
treatment or referral when indicated.  
Results:  A total of 941 patients (N=941) were seen and 65% (n = 607) received a PHQ-2 
screening. The rate of a PHQ-9 screening after scoring  3 on the PHQ-2 was 44% (n = 
42). The rate of patients treated with either medication, referral, or both was 80% (n = 
93). Utilizing a Chi-Square analysis, results indicated a significant (p < .001) relationship 
between PHQ-2 and PHQ-9 screenings, as well as PHQ-9 and treatment.  
Implications for Practice:  Most patients screened with a positive PHQ-2 were likely to 
be screened positive with the PHQ-9.  Likewise, those screened positive with the PHQ-9 
were likely to have some treatment initiated. Patients were identified for depression who 
may not otherwise have been treated.  Screening adult patients with the PHQ-2 and PHQ-
9 depression screening tool contributed to the public health system achieving a 
requirement for PCMH recognition. 
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Aligning with Patient-Centered Medical Home Standards: Depression Screening in 
Primary Care 
Traditional primary care settings often deliver fragmented care and can be 
confusing for patients and providers to navigate when multiple providers are needed 
(Applequist, Miller-Day, Cronholm, Gabbay, & Bowen, 2017). Fragmented care results 
in higher healthcare costs, lower quality of care, and increased rates of preventable 
hospitalizations (Frandsen, Joynt, Rebitzer, & Jha, 2015). An increasingly utilized model 
of care addressing these concerns is the patient-centered medical home (PCMH). The 
objective of a PCMH is to provide the “triple aim” of care: improved quality of care, 
decreased cost, and enhanced experience (National Committee for Quality Assurance 
[NCQA], 2014). The tenets of PCMH include multi-collaborative care across all 
specialties of the health care system, comprehensive care centered around the person as a 
whole, efficient and effective communication approaches, utilization of appropriate 
safety and quality measures, and affordable payment reform (Jackson et al., 2013; Shi et 
al., 2017). Achieving PCMH recognition is a rigorous process usually taking several 
years, but small changes over time have been shown to provide consistent care with 
improved patient outcomes.  
Depression greatly affects individuals 15-years and older and is one of the most 
frequent root causes of disability in the associated population. (Siu & US Preventive 
Services Task Force [USPSTF], 2016). Depression affects up to 13% of patients in the 
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primary care setting, when compared to the depression prevalence of up to 9% in the US 
general population (Maurer, 2012). Depression impacts not only the quality of life of 
patients, but also their families (USPSTF, 2016). In the United States, depression 
treatment costs reached $22.8 billion in 2009, and the cost of lost productivity was an 
additional $23 billion in 2011 (USPSTF, 2016). Current recommendations from the 
USPSTF (2016) reported depression screening should be occurring in the general adult 
primary and specialty care settings, while also including all women receiving prenatal 
and postnatal care. By properly screening these populations, accurate and appropriate 
diagnosis, treatment, and follow-up can be attained (Siu & USPSTF, 2016).  
The PCMH guidelines require the utilization of a validated, standardized 
depression screening tool. One such tool, the Patient Health Questionnaire (PHQ)-2 
screens for depression with a fairly high sensitivity (97%) and a moderate specificity 
(67%) in the adult population (Maurer, 2012). This ultrashort tool has actually been 
found to be as accurate as lengthier, more tedious standardized screening tools such as 
the Beck Depression Inventory or Zung Depression Scale (Maurer, 2012). The PHQ-2 
consists of two simple questions assessing patient anhedonia and mood over the past two 
weeks (Kroenke, Spitzer, & Williams, 2003). Scores range from zero to six, with a score 
of three or more requiring further evaluation with the longer PHQ-9 or by direct 
interview to determine if the patient meets criteria for depression (Kroenke, Spitzer, & 
Williams, 2003). The PHQ-9 is often used as a confirmation of depression when a PHQ-2 
is positive (Maurer, 2012). The PHQ-9 is a validated tool, demonstrating a lower 
sensitivity (61%) than the PHQ-2, but a much higher specificity (94%) for detecting 
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mood disorders in adults (Maurer, 2012). A positive PHQ-2 or PHQ-9 does not always 
indicate depression, thus a positive screen requires provider follow-up.   
Although current recommendations suggested routine depression screenings for 
primary care patients, the rate of screening has been poor. Akincigil and Mathews (2017) 
examined the national rates and patterns of depression screening for patients in a primary 
care setting and found only 4.2% of patients were screened for depression. Also, African 
American and middle age patients were half as likely to be screened when compared to 
white and elderly patients (Akincigil & Mathews, 2017).   
The purpose of this quality improvement initiative was to obtain baseline data to 
describe the use of depression screening tools and depression prevalence among adult 
patients in an internal medicine clinic within a Midwestern public health department. The 
project was to facilitate the public health department in achieving depression screening 
standards necessary to align with PCMH recognition. The questions for this quality 
initiative were:  In patients aged 18-60 years receiving care in the internal medicine clinic 
within a Midwestern public health department during a six-week timeframe: 
1. What was the rate of PHQ-2 depression screenings?  
2. When the PHQ-2 indicated depression risk, what was the rate of PHQ-9 screening? 
 3. Of those patients identified at risk for depression, what was the rate of those 
who  
received medication treatment and/or referral? 
Review of Literature 
Search engines used included Medline, EBSCO HOST, Science Direct, Cochrane, 
PubMed, and the Cumulative Index to Nursing and Allied Health Literature (CINAHL). 
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The keywords used were: patient-centered medical homes, PCMH, medical homes, 
depression screening tool, PHQ-2, depression, family health, internal medicine, and 
primary care. Publications were selected from 2013 to 2017 except one which was 
selected from an expanded search from 2007 to 2017. Inclusion criteria were limited to 
adult patients, PHQ depression screenings, and PCMH. Exclusion criteria were studies 
greater than 10-years old, involving only adolescent or geriatric patients, other depression 
screens, and screening tools for other mental health conditions. 
PCMH recognition is associated with improved patient outcomes, enriched 
clinical decisions, and reduced health care costs. Sinaiko et al. (2017) performed a meta-
analysis of PCMH initiatives across eight states and found the use of specialty visits 
decreased by 1.5% with a total cost savings of 4.2%. Shi et al. (2017) compared all health 
centers with and without PCMH who provided care to over 21 million patients. They 
found there was substantial improvement in treatment for asthma, diabetes, pap 
screenings, prenatal care, and tobacco cessation in health centers that were PCMH 
recognized (Shi et al., 2017).  
Reid et al. (2010) examined overall costs, patients’ perception of the care 
experience, and burnout of providers two years after implementation of a PCMH model. 
They studied before and after evaluations in a random sample of over 6,000 adults treated 
in a PCMH model clinic or one of two control clinics. Reid et al. (2010) found the PCMH 
model enhanced the quality of care, decreased costs, and provided a better overall 
experience for both patients and providers.  
Rosenthal et al. (2016) conducted a three-year study comparing differences in 
patient characteristics and utilization patterns between PCMH and general primary care 
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practices. The authors found a decrease in ED visits by 9.3% yielding an annual savings 
of $5 million dollars (Rosenthal et al., 2016). In addition, cervical cancer screening 
improved (9%), the overuse of colon cancer screenings decreased by 18.1%, and 
hemoglobin A1c values decreased by 0.7% (Rosenthal et al., 2016). PCMH utilization 
also demonstrated a 10.3% decrease in admission rates of patients with multiple 
comorbidities and decreased the frequency of primary care visits by 1.5% (Rosenthal et 
al., 2016). Hence, a PCMH allowed for less frequent but more efficient patient care visits. 
Similarly, the PCMH has been shown to increase alignment with evidence-based 
practice recommendations. Elder et al. (2016) conducted a retrospective chart review to 
assess whether or not PCMH recognition was associated with an increased delivery of 
practice recommendations for chronic pain. Higher rates of key practice 
recommendations were implemented in clinics with or in the process of obtaining a 
PCMH recognition (Elder et al., 2016). This was the first study to assess a PCMH effect 
on chronic pain.  
Nelson et al. (2017) assessed the association between elements of a PCMH and 
the clinical quality in the Veterans Health Administration (VA). Results found higher 
scores on each of eight components in the Progress Index and were related to improved 
quality care indicators (Nelson et al., 2017). Clinics with high care coordination 
performed significantly better on 33 (69%) of 48 quality measures compared to clinics 
with lower care coordination (Nelson et al., 2017). Similar results were noted for access 
(32 [67%]), continuity (29 [60%]), and communication (25 [52%]) (Nelson et al., 2017). 
In fact, all PCMH components contributed to better performance on clinical quality 
indicators. (Nelson et al., 2017). 
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A gap found in the literature was the need for long-term studies related to a 
PCMH and its health outcomes. Although most short-term research has shown PCMH 
recognition as associated with better quality of care and decreased acute care usage, 
further research is necessary to determine whether improved documentation of practice 
guidelines produces sustainable and long-term improvements in patient outcomes. 
Furthermore, evaluating whether populations are healthier in the long-term as a result of a 
PCMH is important.  
Practice guidelines for depression screening and the use of a validated screening 
tool promote optimal patient outcomes and aligns with the standards to become certified 
as a PCMH. Using a validated depression-screening tool can identify the need for further 
assessment, but proper follow-up on a positive screen is important. Fuchs et al. (2015) 
reviewed physician follow-up after a patient received a positive score on the PHQ-2 
screening. They sought to determine if a PHQ-9 screening was subsequently completed 
and if there were any changes in treatment. The PHQ-2 was used to screen 1,744 patients 
for depression, for which over 400 (24%) screened positive (Fuchs et al., 2015). 
However, only 20 (5%) of those patients received a PHQ-9 screening (Fuchs et al., 2015). 
Furthermore, of the patients who tested positive on the PHQ-2 screening, 21% had initial 
chief complaints of mental health concerns (Fuchs et al., 2015). Discussion of depression 
was found in 39% of charts, any mental health concerns was found in 55% of charts, and 
treatment options were discussed in 38% of charts. This study was limited to EHR 
documentation, so if discussions occurred that weren’t documented they were not 
included (Fuchs et al., 2015). In summary, the authors concluded that PHQ-2 screening 
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did not substantially improve further assessment, follow-up, or alteration in treatment 
related to depression (Fuchs et al., 2015).  
Although routine depression screenings have the potential to identify depression 
risks, they are only effective if a positive screen leads to further evaluation and changes 
in care. Screening instruments can identify depression risk in adult patients, but the 
finding of depression warrants evaluation and treatment to improve patient outcomes; 
therefore, system changes may be required to appropriately integrate evidence-based 
depression screening. Primary care settings may benefit from behavioral health referral 
services in an attempt improve rates of depression screening, routine follow-up, and 
proper treatment (Fuchs et al., 2015).  
 The Plan-Do-Study-Act (PDSA) quality improvement method is a scientific 
method used to test change. The PDSA helps to provide a foundation, guide a project, 
and establish boundaries for testing change. This method is well reviewed within health 
care quality improvement initiatives. Taylor et al. (2013) discussed the application of the 
PDSA method to improve quality in healthcare. The ‘plan’ stage of the cycle helps 
identify the change that is needed and determine appropriate interventions. During the 
‘plan’ stage of this project, gaps in the process are identified. Once an intervention is 
planned, the cycle moves to the ‘do’ stage. During this stage, the intervention is put into 
motion. During the next step of the cycle, the effects of the intervention are evaluated or 
“studied”. Last, the ‘act’ step of the cycle examines any further changes necessary to 
continually improve the process (Taylor et al., 2013).  
Methods 
Design  
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This was a quality improvement project utilizing a descriptive and observational 
design. A retrospective medical record review was used to assess the rate of depression 
screening utilizing the PHQ-2 and PHQ-9.  In addition, any treatment (including 
referrals) in adult patients seen in an internal medicine primary care clinic over a six-
week period was recorded.  This was the first cycle utilizing the PDSA method. 
Setting  
The setting was a Midwestern suburban public health department serving 
approximately one million residents. There were 41,000 visits in 2016. Included within 
this department were three free-standing clinics serving racially, ethnically, and 
economically diverse patients throughout the county. Services included primary care in 
internal medicine, women's health, pediatrics, and dental services. 
Sample  
A convenience sample of patients who sought care at the internal medicine clinic 
from February 15-March 31, 2018 was obtained. Inclusion criteria were:  patients aged 
18-60 years, annual physical exam, routine follow-up, new patient, or a mental health 
chief complaint. Visits for episodic care were included if the patient had not been 
screened in over a year. Exclusion criteria included patients less than 18- or greater than 
60-years of age, women who were pregnant or up to 6-months postpartum, and 
appointments for scheduled procedures.  
Approval Process  
The project was approved by the public health department’s internal research 
review committee (IRRC).  In addition, institutional review board (IRB) approval was 
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attained from the University of Missouri-St. Louis. There were no known risks or ethical 
considerations related to this study.  
Data Collection and Analysis  
Data was collected via a retrospective medical record review. Data was collected 
by the public health department’s electronic health record (EHR) specialists, who 
produced bi-weekly reports. Demographic data included age, gender, race, and payor 
status. In addition, the type of visit, type of depression screening, and any recommended 
treatments or referrals was collected. If a PHQ-9 screening was positive for depression, 
the primary investigator accessed the EHR to determine method of follow up. Data was 
stored on a password-protected computer by the primary investigator. All data was de-
identified and coded by using a subject ID such as A1, A2, A3, etc., for the entirety of the 
data set.  
Procedures  
A quality improvement team was formed and included the medical director, a 
public health nurse, the manager of information technology (IT) operations, and the 
manager of behavioral health. The team communicated through face-face meetings, 
emails, and telephone calls to discuss progress, concerns, and recommendations 
throughout the process. Providers and staff were educated about PCMH and the benefits 
of achieving certification, the significance of depression screening, the PHQ-2 and PHQ-
9 screening tools, as well as the follow-up steps including medication management, 
treatment, and/or referral. Resources included adding the PHQ-9 screening tool into the 
EHR, and well as adjusting the documentation process for the depression screenings. The 
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EHR specialist was used as an additional resource to obtain patient data. A final meeting 
occurred after completion of data analysis to discuss results and future recommendations. 
Results 
Summary descriptive statistics were calculated for each interval and ratio 
variable. Frequencies and percentages were calculated for each nominal variable.  
Between February 15 through March 31, 2018, there was a total number of approximately 
941 internal medicine patient visits (N=941) that aligned with the inclusion and exclusion 
criteria. Based on the number of patient visits, the most frequently observed category of 
gender was Female (n = 589, 63%). The most frequently observed category of race was 
Black (n = 492, 52%). The most frequently observed category of payor status was 
Gateway to Better Health (n = 406, 43%). The average age of patients screened was 
46.16 years (SD = 10.79) (Appendix A). 
Approximately 65% (n = 607) of patients received a PHQ-2 screening.  The most 
frequently observed PHQ-2 score was negative, meaning a score of <3 (n = 490, 80%). 
The least frequently observed PHQ-2 score was a refusal of screening by patient (n =3, 
0.4%). The rate of patients who received a score of  3 on the PHQ-2 was 16% (n = 96). 
The rate of patients who were given a PHQ-9 screening after scoring a  3 on the PHQ-2 
was 44% (n = 42). A select number of patients with a history of depression were directly 
screened with the PHQ-9, bypassing the PHQ-2 (n =18).  There was an 80% rate of 
patients who were treated with either medication (n =30), referral to behavioral health or 
social services (n=23), or both medication and referral (n =40), following a positive 
depression screening. Depression interventions were not addressed in 20% (n =23) of the 
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provider notes where patients that had a positive depression screen and 7% (n =8) of 
patients declined treatment.  
  A Chi-Square Test of independence was conducted to examine the relationship 
between PHQ-2 and PHQ-9 screenings. There were four levels in the PHQ-2 variable: 
Negative, Positive, Refused, and and X (which represents bypassing the PHQ-2 due to 
history of depression). There were three levels in the PHQ-9 variable: Not applicable to 
patient, Not done, and Received. The results of the Chi-Square test were significant, χ2(6) 
= 664.18, p < .001, indicating if the PHQ-2 was positive, the PHQ-9 was likely positive 
for a mental health condition such as depression. The PHQ-2 positive screening variable 
and the PHQ-9 received variable had observed values that were greater than their 
expected values (Appendix B).  
An additional Chi-Square Test of independence was conducted to examine the 
relationship between PHQ-9 screenings and recommended treatment and/or referral. 
There were three levels in PHQ-9: Not applicable to patient, Not done, and Received. 
There were six levels in recommended treatment and/or referral: Medication, Referral, 
Medication and Referral, Declined Treatment, Not Addressed, and No treatment 
indicated. The results of the Chi-Square test were significant, χ2(10) = 579.02, p < .001, 
indicating a positive PHQ-9 resulted in treatment and/or referral to a mental health 
specialist (Appendix C). The following level combinations had observed values that were 
greater than their expected values: PHQ-9 received and Medication and Referral, PHQ-9 
received and Medication, PHQ-9 received and Referral, PHQ-9 received and 
interventions not addressed, PHQ-9 received and declined treatment.  
Discussion 
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Results in this study demonstrated the rate of PHQ-2 screenings were high using a 
carefully constructed PDSA method. Almost seven out of every 10 visits were screened 
with the PHQ-2 depression screening tool. While the majority of patients who received a 
score of  3 on the PHQ-2 screening did not receive a reflex to the PHQ-9 screening, the 
relationship between these two variables remained significant in that a positive PHQ-2 or 
PHQ-9 likely indicated a mental health condition such as depression (p < .001). When 
patients were positively screened for depression, the vast majority of patients (80%) were 
treated with medication, referral, or both (p < .001). When patients were treated with 
medication, it was found that new medication was started, medication dosages were 
adjusted, or additional medications were added to current regimen. When patients were 
referred to behavioral health or social services, they were referred to psychiatry, social 
work services, or counseling. When a positive depression screening was not addressed, 
discussion of treatment was not documented in the providers visit note. It is unknown if 
depression treatment was discussed and not documented.  
 Based on the results of this study, the continuation of depression screenings with 
the PHQ-2 and PHQ-9 standardized depression screening tools is recommended. The 
PHQ-2 screening is ultrashort, easy to administer, and has shown an impressive rate of 
compliance, demonstrating this to be an appropriate tool for patients with no history of 
depression. When patients score a  3 on the PHQ-2, the PHQ-9 should be utilized. 
Because of the increased specificity and decreased sensitivity of the PHQ-9, patients with 
a history of depression should be screened with the PHQ-9, bypassing the PHQ-2. 
Providers might benefit from documentation of any recommended treatment for positive 
screenings. When patients decline screening and/or treatment, a recommendation would 
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be to routinely document this in the provider’s visit note. Sustainability in screenings may 
occur if monthly audits occur and discussion about the rates and results a part of staff 
meetings.  
Conclusion 
The implementation of the PHQ-2 and PHQ-9 screenings were successfully 
implemented when no prior standardized depression screening was routinely used. 
Accessibility to the PHQ-2 and PHQ-9 in the EHR may enhance its use.  The 
implementation of a standardized depression screening tool assisted the public health 
system to be increasingly prepared to achieve PCMH recognition. A PCMH recognition 
aligns with the triple aim of improved quality of care, decreased cost, and enhanced 
patient and provider experiences.  
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Appendix A 
Table 1 
Frequency Table for Nominal Variables 
Variable n % 
Appt_Type_descr     
    FOLLOW-UP 746 79.28 
    NEW PATIENT 156 16.58 
    PHYSICAL 39 4.14 
    Missing 0 0.00 
Patient_Sex     
    F 589 62.59 
    M 352 37.41 
    Missing 0 0.00 
Patient_Race     
    AMERICAN INDIANALASKAN NATIVE 3 0.32 
    ASIAN 21 2.23 
    BLACK 492 52.28 
    OTHER RACE 14 1.49 
    WHITE 411 43.68 
    Missing 0 0.00 
Prim_Policy_Carrier_Name     
    AETNA PPO 3 0.32 
    AMBETTER FROM HOME STATE HLTH 4 0.43 
    ANTHEM BLUE CROSS BLUE SHIELD 26 2.76 
    CIGNA HEALTHCARE 41 4.36 
    COVENTRY 2 0.21 
    GATEWAY TO BETTER HEALTH 406 43.15 
    HEALTHLINK CORP 1 0.11 
    HOME STATE HEALTH PLAN 28 2.98 
    MEDICAID 189 20.09 
    MEDICARE 108 11.48 
    UNINSURED 113 12.01 
    UNITED HEALTHCARE 18 1.91 
    UNITED MEDICAL RESOURCES 2 0.21 
    Missing 0 0.00 
Note. Due to rounding errors, percentages may not equal 100%. 
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Appendix B 
Table 2 
Observed and Expected Frequencies 
  PHQ_9 
PHQ_2 Not applicable to patient Not done Received 
Neg 484[393.13] 5[46.82] 1[50.05] 
Pos 0[77.02] 53[9.17] 43[9.81] 
Refused 3[2.41] 0[0.29] 0[0.31] 
X 0[14.44] 0[1.72] 18[1.84] 
Note. χ2(6) = 664.18, p < .001. Values formatted as Observed[Expected]. 
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Appendix C 
Table 3 
Observed and Expected Frequencies 
                Recommended Treatments and/or Referrals 
PHQ_9 
Declined 
Treatment 
Medication 
Medication 
and 
Referral 
Not 
Addressed 
No 
treatment 
indicated 
Referral 
Not 
applicable 
to patient 
0[6.42] 5[24.07] 0[36.10] 0[20.06] 481[386.71] 1[13.64] 
Not done 4[0.76] 11[2.87] 22[4.30] 10[2.39] 1[46.06] 10[1.62] 
Received 4[0.82] 14[3.06] 23[4.60] 15[2.55] 0[49.23] 6[1.74] 
Note. χ2(10) = 579.02, p < .001. Values formatted as Observed[Expected]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
